A low-dose CT scan is a specialized type of computed tomography that produces detailed images of the body using significantly less radiation than a standard CT. It’s most commonly used to screen for lung cancer in people at high risk, and it’s the only screening test proven to reduce lung cancer deaths. The scan delivers roughly 1 to 2 millisieverts of radiation, compared to about 7 mSv for a conventional chest CT, making it closer to a mammogram than a traditional scan in terms of exposure.
How It Differs From a Standard CT
A CT scanner works by rotating an X-ray beam around your body and assembling the images into detailed cross-sectional slices. A low-dose CT (LDCT) uses the same basic technology but dials down the radiation output by adjusting settings like the voltage and electrical current of the X-ray tube and the speed of the tube’s rotation. There’s no single agreed-upon threshold for what counts as “low dose,” but in major clinical trials, the effective dose has ranged from 0.2 mSv to about 2.4 mSv per scan.
The reason this works particularly well for the lungs is simple physics: air and solid tissue (like a nodule) have very different densities, creating high natural contrast on the image. You don’t need as much radiation to distinguish between the two. Newer scanner software also helps. Modern machines use advanced image-processing algorithms that reduce the visual “noise” caused by lower radiation without sacrificing image clarity.
What the Scan Is Used For
The primary use of LDCT is lung cancer screening. The landmark National Lung Screening Trial, which enrolled more than 53,000 people, found that screening high-risk individuals with LDCT reduced lung cancer deaths by 20% compared to standard chest X-rays. That finding changed clinical guidelines and made LDCT the recommended screening method for people who meet certain criteria, generally adults aged 50 to 80 with a significant smoking history.
LDCT is also used in some other clinical situations where repeated imaging is needed and minimizing cumulative radiation exposure matters. Examples include monitoring known lung nodules over time, screening for kidney stones, and certain pediatric imaging. But lung cancer screening remains by far its most prominent application.
What the Experience Is Like
If you’re imagining a complicated medical procedure, the reality is far simpler. The entire exam takes less than 10 minutes. You lie on a table that slides into a large, doughnut-shaped scanner, hold your breath for a few seconds while the images are captured, and you’re done. No needles, no contrast dye injected into your veins, no fasting beforehand. You can eat normally before and after. There’s no recovery time, and you leave the facility immediately.
Understanding Your Results
Lung cancer screening results are reported using a scoring system called Lung-RADS, which categorizes findings on a scale that tells your doctor what to do next. Knowing the basics can help you make sense of your report.
- Category 1 (Negative): No nodules found. Continue annual screening.
- Category 2 (Benign appearance): Nodules are present but very unlikely to be cancerous based on their size or stability. Continue annual screening.
- Category 3 (Probably benign): A finding that’s likely harmless but warrants a follow-up scan in 6 months to confirm it isn’t growing.
- Category 4A (Suspicious): A nodule large enough or new enough to need a closer look, typically with a repeat scan in 3 months or additional imaging.
- Category 4B (Very suspicious): A larger or growing nodule that may require a biopsy or additional specialized imaging.
The vast majority of people who get screened will fall into categories 1 or 2. A higher category does not mean you have cancer. It means additional information is needed.
False Positives Are Common
One of the most important things to understand about LDCT screening is its high false-positive rate. A false positive means the scan flags something that looks suspicious but turns out not to be cancer. In the National Lung Screening Trial, roughly 24% of baseline scans were flagged as positive, and the vast majority of those were ultimately benign. A systematic review of 20 studies found a median false-positive rate of about 20% on first-time screens, dropping to around 9.5% on subsequent rounds.
When a scan does flag a suspicious nodule, the follow-up process can range from a simple repeat scan in a few months to additional imaging with a PET scan or, less commonly, a biopsy. In studies tracking these outcomes, nonsurgical biopsies were performed in roughly 1% to 4% of all people screened, and surgical removal of a nodule occurred in about 1% to 6%. Among those who did have surgery, anywhere from 6% to 45% turned out to have benign findings, meaning the surgery was ultimately unnecessary. These numbers illustrate why understanding the possibility of false alarms matters before you decide to get screened.
Overdiagnosis: Finding Cancers That Won’t Cause Harm
Beyond false positives, there’s a subtler risk called overdiagnosis. This is when LDCT detects a real cancer that is so slow-growing it would never have caused symptoms or threatened your life. An analysis of data from the National Lung Screening Trial estimated that roughly 18.5% of all lung cancers detected by LDCT were overdiagnosed. For the most common type of lung cancer (non-small cell), the overdiagnosis rate was about 22.5%.
The concern is that these individuals go through the stress, expense, and potential complications of cancer treatment for a tumor that wouldn’t have harmed them. With longer follow-up modeling, researchers found that true overdiagnosis for most lung cancer types dropped to around 3%, suggesting many of these slow-growing cancers would eventually become relevant given enough time. Still, the possibility of being treated for a cancer you didn’t need to know about is a real trade-off of screening.
Radiation Risk in Perspective
The average American absorbs about 3 mSv of radiation annually just from natural background sources like radon, cosmic rays, and the soil. A single LDCT scan delivers roughly 1 to 2 mSv, so it’s comparable to a few months of everyday environmental exposure. By comparison, a standard chest CT delivers about 7 mSv, and a full abdominal CT can reach 10 mSv or more.
To date, no study has demonstrated a direct link between radiation at these low levels (under 100 mSv) and an increased cancer risk. The theoretical concern is based on extrapolations from much higher doses. For someone getting an annual screening scan, the cumulative exposure over a decade of yearly tests remains well below thresholds where measurable harm has been observed.